Sometimes you have to admit it. Things didn’t work out the way you wanted and it’s not great.
That’s what Tim Collins has to say in his space on RealMoney: “Timing is everything.”
Recently Collins wrote that his position in Draganfly DFLYF seemed ready to pay off and pay off quite well. A week later, he hadn’t exactly reversed his position. But he wasn't as happy about Draganfly as he was originally.
“I misjudged the big money demand for both Draganfly and CurrencyWorks (CWRK). I definitely overestimated where....More>>>
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new every day.
While the world’s leading biotech companies — churning out Covid-19 vaccines and treatments — have hit record share prices, their small-cap rivals have been sinking. But some analysts say the latest figures suggest a bargain in the sector.
Alone In The Red
Pfizer’s share price hit a record high for the first time in 20 years this month, topping $48, while vaccine....More>>>